Results 251 to 260 of about 216,413 (307)

Stress-Inducible Transcription Factor NUPR1 Is Involved in the Inhibitory Effects Exerted by Statins on Insulin Action in ER-Positive Breast Cancer Cells. [PDF]

Cells
Scordamaglia D, Zicarelli A, Cirillo F, Talia M, De Francesco EM, Malaguarnera R, Maggiolini M, Lappano R.   +7 more
europepmc   +1 more source

Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors. [PDF]

J Clin Med Res
Patel J, Shah S, Reddy A, Prajapati D, Pandya A, Sawhney S.   +5 more
europepmc   +1 more source

Statin therapy and stroke risk in patients with hypercholesterolaemia: a population-based longitudinal study using electronic health records in South London. [PDF]

BMC Med
Delord M, Douiri A.
europepmc   +1 more source

The effect of medication use on chronic pruritus in patients with type 2 diabetes mellitus: a multicenter cross-sectional study. [PDF]

Sci Rep
Xu M, Gao X, Liu Z, Zhang L, Wang Z, Zhuang H, Fu W, Yao S, Zhang L, Zhou S, Liu J.   +10 more
europepmc   +1 more source

Dyslipidemia in Diabetes: Navigating a Complex Landscape for Improved Cardiovascular Outcomes. [PDF]

Clin Med Insights Endocrinol Diabetes
Abdul Wahab R, Wan Mahmood WA.
europepmc   +1 more source

Statin Therapy and Clinical Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Gillani I, Muneeb Ullah M, Postoev A, Sharma A, Mohammed Abdul RH, Chaudhary S, Gunaratne H, Allahwala D.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Statins in Atherothrombosis

Seminars in Vascular Medicine, 2004
Clinical studies have shown that hydroxy-methyl glutaryl coenzyme A reductase inhibitors (statins) may favorably affect atherothrombosis. In addition to their potent cholesterol-lowering properties, statins reduce atheroma progression as well as the incidence of acute thrombosis-related vascular events and their dreadful clinical consequences ...
S. Colli, J. P. Werba, E. Tremoli
openaire   +2 more sources

Statins and the Liver

Endocrinology and Metabolism Clinics of North America, 2015
Lipid lowering, particularly with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors ("statins"), reduces the risk of cardiovascular disease. Patients with chronic liver disease present challenges to the use of lipid medications. In the case of most liver disorders, the concern has been one of safety.
Cynthia, Herrick, Samira, Bahrainy, Edward A, Gill   +2 more
openaire   +3 more sources

Statins and Diabetes

Cardiology Clinics, 2015
A statin is first-line drug therapy for dyslipidemia. Clinical trial data suggest there is an increase in the incidence of new-onset type 2 diabetes mellitus with statin use. The National Lipid Association (NLA) Statin Diabetes Safety Task Force concluded that the cardiovascular benefit of statin therapy outweighs the risk for developing diabetes.
Kevin C, Maki, Mary R, Dicklin, Seth J, Baum   +2 more
openaire   +3 more sources